Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent recombinant HPV vaccine (yeast) in 9-45-year-old females
CTR20171447Phase 2Completed
- Sponsor
- Sinopharm
- Start
- Dec 2017
- Countries
- 1
01
Overview
A Phase 2 trial of quadrivalent human papillomavirus vaccine in human papillomavirus infection, sponsored by Sinopharm. Started Dec 2017; status: completed.
02
Drugs
quadrivalent human papillomavirus vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on CTR20171447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171447.